INS and Hyperglycemia: Moreover, intravenous infusion of PGE2 to rats decreased insulin secretion in response to glucose and, by using a transgenic mouse model overexpressing COX2 and PGE2 synthase-1, reduced insulin level and hyperglycaemia were demonstrated [22, 23].